Virbac Dirección

Dirección controles de criterios 4/4

El CEO de Virbac's es Sebastien Huron , nombrado en Dec 2012, tiene una permanencia de 11.33 años. compensación anual total es €2.45M, compuesta por 14.5% salario y 85.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.025% de las acciones de la empresa, por valor de €755.99K. La antigüedad media del equipo directivo y de la junta directiva es de 3.1 años y 3.3 años, respectivamente.

Información clave

Sebastien Huron

Chief Executive Officer (CEO)

€899.0k

Compensación total

Porcentaje del salario del CEO	42.2%
Permanencia del CEO	3.4yrs
Participación del CEO	0.04%
Permanencia media de la dirección	3.2yrs
Promedio de permanencia en la Junta Directiva	3.4yrs

Actualizaciones recientes de la dirección

Recent updates

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Mar 22

Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 05

Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Dec 18

Estimating The Fair Value Of Virbac SA (EPA:VIRP)

Dec 01

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Nov 18

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Sebastien Huron en comparación con los beneficios de Virbac?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	€899k	€379k	€121m
Sep 30 2023	n/a	n/a	€120m
Jun 30 2023	n/a	n/a	€119m
Mar 31 2023	n/a	n/a	€121m
Dec 31 2022	€2m	€355k	€122m
Sep 30 2022	n/a	n/a	€120m
Jun 30 2022	n/a	n/a	€119m
Mar 31 2022	n/a	n/a	€116m
Dec 31 2021	€884k	€339k	€113m
Sep 30 2021	n/a	n/a	€137m
Jun 30 2021	n/a	n/a	€161m
Mar 31 2021	n/a	n/a	€148m
Dec 31 2020	€590k	€357k	€136m
Sep 30 2020	n/a	n/a	€104m
Jun 30 2020	n/a	n/a	€72m
Mar 31 2020	n/a	n/a	€62m
Dec 31 2019	€555k	€325k	€52m
Sep 30 2019	n/a	n/a	€43m
Jun 30 2019	n/a	n/a	€34m
Mar 31 2019	n/a	n/a	€27m
Dec 31 2018	€719k	€325k	€20m
Sep 30 2018	n/a	n/a	€8m
Jun 30 2018	n/a	n/a	-€4m
Mar 31 2018	n/a	n/a	-€3m
Dec 31 2017	€311k	€265k	-€3m

Compensación vs. Mercado: La compensación total de Sebastien($USD965.13K) está por debajo de la media de empresas de tamaño similar en el mercado French ($USD1.92M).

Compensación vs. Ingresos: La compensación de Sebastien ha sido consistente con los resultados de la empresa en el último año.

CEO

Sebastien Huron (52 yo)

3.4yrs

Permanencia

€899,021

Compensación

Mr. Sebastien Huron has been Chief Executive Officer since December 15, 2020. He served as the Head of Global Business Operations at Virbac SA since 2014 and has been its Member of Executive Board since De...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Sebastien Huron	Chief Executive Officer	3.4yrs	€899.02k	0.041% € 1.2m
Habib Ramdani	CFO & Deputy CEO	7.9yrs	€442.92k	0.014% € 429.7k
Marc Bistuer	Deputy CEO and Director of Corporate Quality & Compliance	1.3yrs	€396.22k	0.088% € 2.6m
Sandrine Brunel	Head of Corporate Communications	no data	sin datos	sin datos
Nathalie Pollet	Head of Global Marketing & Market Development	3.3yrs	sin datos	sin datos
Francesca Cortella	Head of Corporate Human Resources	no data	sin datos	sin datos
Sophie Favini	Head of Global Business Operations	2.3yrs	sin datos	sin datos
Bertrand Havrileck	Head of Corporate R&D	3.1yrs	sin datos	sin datos
André Mathieu	Head of Global Industrial Operations	no data	sin datos	sin datos
Manuela Rodríguez	Director of Financial Projects	no data	sin datos	sin datos

3.2yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de VIRP se considera experimentado (3.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Pierre Madelpuech	Vice Chairman of the Board of Directors	3.4yrs	€27.00k	0.0013% € 39.3k
Marie-Helene Dick-Madelpuech	Chairwoman of Board of Directors	3.4yrs	€137.00k	50.22% € 1.5b
Xavier Yon	Non-Voting Advisor	no data	€24.00k	sin datos
Olivier Charmeil	Independent Director	less than a year	sin datos	0.00012% € 3.6k
Philippe Gaston Capron	Member of Board of Directors	3.4yrs	€30.00k	0.0053% € 158.2k
Cyrille Petit	Independent Member of Board of Directors	3.4yrs	€27.00k	0.0031% € 93.2k
Solene Madelpuech	Members of the Board of Directors	3.4yrs	€27.00k	0.00012% € 3.6k
Sylvie Gueguen	Employee Representative Director	3.4yrs	sin datos	0.0016% € 49.4k
Rodolphe Durand	Non-Voting Advisor	no data	€24.00k	sin datos

3.4yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de VIRP se considera experimentada (3.3 años de antigüedad promedio).

Virbac Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Virbac SA, Annual General Meeting, Jun 21, 2021

Recent updates

Full year 2023 earnings released: EPS: €14.40 (vs €14.43 in FY 2022)

Virbac SA (ENXTPA:VIRP) acquired Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591).

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Full year 2023 earnings: EPS misses analyst expectations

Virbac SA (ENXTPA:VIRP) entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591) for an enterprise value of approximately €280 million.

Virbac SA Provides Earnings Guidance for the Year 2024

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Now 21% undervalued

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Virbac SA to Report Fiscal Year 2023 Results on Mar 19, 2024

Price target increased by 11% to €327

Investor sentiment improves as stock rises 15%

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

First half 2023 earnings released: EPS: €8.86 (vs €9.18 in 1H 2022)

Virbac SA Confirms Revenue Forecasts for the Year 2023

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Upcoming dividend of €1.32 per share at 0.5% yield

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

Is Virbac (EPA:VIRP) Using Too Much Debt?

Full year 2022 earnings released: EPS: €14.44 (vs €13.40 in FY 2021)

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA to Report First Half, 2023 Results on Sep 14, 2023

Virbac SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Price target decreased to €341

Investor sentiment deteriorated over the past week

Price target decreased to €348

Virbac SA Provides Revenue Guidance for the Year 2022

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: €9.18 (vs €8.54 in 1H 2021)

Investor sentiment deteriorated over the past week

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Upcoming dividend of €1.25 per share

Full year 2021 earnings: EPS exceeds analyst expectations

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Virbac SA Provides Revenue Guidance for the Year 2022

Price target increased to €435

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Price target increased to €416

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Is Virbac (EPA:VIRP) Using Too Much Debt?

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Price target increased to €367

Virbac SA (ENXTPA:VIRP) acquired an additional 15% stake in Centrovet group for $17.7 million.

Price target increased to €341

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Consensus EPS estimates increase to €10.34

Price target increased to €305

Virbac SA Raises Revenue Guidance for 2021

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Upcoming dividend of €0.75 per share

Is Virbac (EPA:VIRP) A Risky Investment?

Friulchem S.p.A. (BIT:FCM) signed a preliminary agreement to acquire Business Unit of Virbac SA (ENXTPA:VIRP) for €2.5 million.

Price target increased to €263

Consensus EPS estimates increase to €8.18

Investor sentiment improved over the past week

Virbac SA Revises Earnings Guidance for the Year 2021

Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Full year 2020 earnings released: EPS €16.29 (vs €6.11 in FY 2019)

Virbac SA Proposes Dividend for the 2020 Financial Year

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Virbac SA to Report Fiscal Year 2020 Results on Mar 17, 2021

New 90-day low: €203

Algenex and Virbac Signs International Commercial Licensing Agreement for Crisbio-Based Vaccine in Major Swine Indication